Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 USD | +0.84% | +7.23% | -24.31% |
May. 15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
Apr. 25 | Top Premarket Gainers | MT |
Chart calendar Cidara Therapeutics, Inc.
Upcoming events on Cidara Therapeutics, Inc.
Past events on Cidara Therapeutics, Inc.
2024-05-15 04:20 pm | Q1 2024 Earnings Release |
2024-04-27 06:00 am | European Society of Clinical Microbiology and Infectious Diseases Conference - Presenter: Roxana E. |
2024-04-27 06:00 am | European Society of Clinical Microbiology and Infectious Diseases Conference - Presenter: Ruben Fael |
2024-04-24 04:30 pm | Business Update Call |
2024-04-22 05:10 pm | Q4 2023 Earnings Release |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Simon Döhrmann |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Amanda Almaguer |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - James Levin |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Elizabeth Abelovski |
2024-04-04 11:00 am | Extraordinary Shareholders Meeting |
2024-02-27 | Q4 2023 Earnings Release (Projected) |
2023-12-07 06:00 am | European Society for Medical Oncology Immuno Oncology Congress - Discovery of a Novel, Dual CD73 & P |
2023-12-07 06:00 am | European Society for Medical Oncology Immuno Oncology Congress - Discovery of CBO421, a First-in-Cla |
2023-11-03 03:00 pm | Society for Immunotherapy of Cancer Meeting |
2023-11-02 04:15 pm | Q3 2023 Earnings Release |
2023-10-14 12:15 pm | IDWeek Conference - James Levin |
2023-10-14 12:15 pm | IDWeek Conference - Shawn Flanagan |
2023-10-14 10:30 am | IDWeek Conference - James Levin |
2023-09-21 12:00 pm | R&D Day |
2023-09-11 10:00 am | H.C. Wainwright Global Investment Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 20,9 17,1 22.67% | 12,1 18,5 -34.89% | 49,6 46,6 6.28% | 64,3 64,7 -0.62% | 63,9 57,8 10.47% | 12,2 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -41,7 -47,4 11.9% | -71,8 -60,9 -17.92% | -42,3 -47,1 10.21% | -29,7 -28,4 -4.82% | -24,5 -28,1 12.97% | -87,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,1 -41,9 2.04% | -72,1 -61,1 -18.06% | -42,5 -47,5 10.66% | -29,5 -28,3 -4.37% | -22,5 -26,3 14.63% | -85,0 |
Net income Million USD | Released Forecast Spread | -41,1 -42,1 2.42% | -74,9 -62,4 -19.9% | -42,5 -47,9 11.39% | -29,8 -30,4 1.82% | -22,9 -27,4 16.29% | -85,0 |
EPS USD | Released Forecast Spread | -28,2 -27,7 -1.84% | -36,0 -30,9 -16.5% | -16,2 -17,7 8.3% | -8,60 -8,33 -3.2% | -5,20 -6,13 15.22% | -17,5 |
Announcement Date | 04/03/20 | 25/02/21 | 07/03/22 | 23/03/23 | 22/04/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7,11 4,71 50.86% | 6,22 4,97 25.2% | 40,7 22,7 79.67% | 10,2 10,6 -3.29% | 26,0 18,7 39.11% | 7,61 11,5 -34.06% | 12,7 8,14 56.25% | 17,6 11,5 52.34% | 8,46 9,03 -6.31% | 1,30 | 1,30 | 1,20 |
EBIT Million USD | Released Forecast Spread | -18,3 -19,2 4.75% | -13,1 -19,3 32.06% | 14,9 5,83 156.13% | -13,3 -11,9 -11.49% | 2,98 -3,28 190.67% | -12,8 -12,4 -3.31% | -8,56 -15,2 43.68% | -3,68 -9,86 62.71% | -10,7 -11,3 5.67% | -19,8 | -25,8 | -30,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,3 -19,2 4.83% | -13,1 -19,2 31.73% | 15,0 5,81 157.63% | -13,1 -11,9 -10.28% | 3,21 -3,13 202.42% | -12,2 -12,3 0.51% | -7,94 -13,6 41.51% | -3,15 -9,53 66.94% | -10,3 -11,0 6.13% | -19,3 | -25,3 | -30,2 |
Net income Million USD | Released Forecast Spread | -18,3 -19,2 4.83% | -13,1 -19,3 32.18% | 11,9 5,81 104.64% | -13,4 -11,9 -12.57% | 2,53 -3,13 180.81% | -12,4 -12,3 -0.71% | -8,17 -13,6 39.81% | -3,21 -9,53 66.27% | -10,3 -11,0 6.13% | -19,3 | -25,3 | -30,2 |
EPS USD | Released Forecast Spread | -5,40 -5,56 2.88% | -3,80 -5,60 32.14% | 3,40 1,35 151.85% | -3,80 -2,93 -29.55% | 0,60 -0,73 181.82% | -2,80 -2,60 -7.69% | -1,80 -3,00 40% | -0,80 -2,07 61.29% | -2,28 -2,39 4.47% | -4,10 | -5,05 | -5,80 |
Announcement Date | 11/05/22 | 09/08/22 | 03/11/22 | 23/03/23 | 11/05/23 | 03/08/23 | 02/11/23 | 22/04/24 | 15/05/24 | - | - | - |
Past sector events for Cidara Therapeutics, Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CDTX Stock
- Calendar Cidara Therapeutics, Inc.